ACVR1B |
Activin receptor type-1B |
ASAH2 |
N-acylsphingosine amidohydrolase-2 |
BAMBI |
Activin membrane-bound inhibitor homolog |
CCT |
Cranial computer tomography |
CPR |
Cardiopulmonary resuscitation |
CRH |
Corticotropin-releasing hormone |
CRHR1 |
Corticotropin-releasing hormone receptor-1 |
CRHR2 |
Corticotropin-releasing hormone receptor-2 |
CSF2RB |
Cytokine receptor common subunit beta |
DNA |
Desoxyribonucleid acid |
EEG |
Electroencephalography |
ERC |
European resuscitation council |
FC |
Fold change |
GO |
Gene ontology |
HIBI |
Hypoxic−ischemic brain injury |
ICU |
Intensive care unit |
IL-1A |
Interleukin-1-alpha |
IL1R2 |
Interleukin-1 receptor type 2 |
IL5 |
Interleukin-5 |
IL5RA |
Interleukin-5 receptor subunit alpha |
INHBA |
Inhibin subunit beta A |
IRAK4 |
Interleukin-1 receptor-associated kinase 4 |
JAM-B |
Junctional adhesion molecule B |
JAM3 |
Junctional adhesion molecule 3 |
LAYN |
Layilin |
LOD |
Lower detection limit |
NPX |
Normalized protein expression |
NSE |
Enolase-2 |
NUCB2 |
Nucleobindin-2 |
N2DL-2 |
NKG2D ligand-2 |
n-CDase |
Neutral ceramidase |
OHCA |
Out-of-hospital cardiac arrest |
PCR |
Polymerase chain reaction |
PEA |
Proximity extension assay |
PIGK |
Phosphatidylinositol glycan anchor biosynthesis class K LTB |
PT |
Prothrombin time |
PTK7 |
Tyrosin protein kinase 7 |
PTT |
Partial thromboplastin time |
QC |
Quality control |
ROSC |
Return of spontaneous circulation |
SEP |
Somatosensory-evocable potentials |
Siglec-9 |
Sialic acid-binding immunoglobulin-like lectin 9 |
SOP |
Standard operating procedure |
SOX30 |
SRY-box transcription factor 30 |
STX8 |
Syntaxin 8 |
TNF-B |
Tumour necrosis factor |
TTM |
Targeted temperature management |
UMOD |
Uromodulin |
VTI1A |
Vesicle transport through interaction with T-SNAREs 1A |
VTI1B |
Vesicle transport through interaction with T-SNAREs 1B |